192 related articles for article (PubMed ID: 23737250)
1. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.
Järlestedt K; Rousset CI; Ståhlberg A; Sourkova H; Atkins AL; Thornton C; Barnum SR; Wetsel RA; Dragunow M; Pekny M; Mallard C; Hagberg H; Pekna M
FASEB J; 2013 Sep; 27(9):3797-804. PubMed ID: 23737250
[TBL] [Abstract][Full Text] [Related]
2. C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.
Pozo-Rodrigálvarez A; Li Y; Stokowska A; Wu J; Dehm V; Sourkova H; Steinbusch H; Mallard C; Hagberg H; Pekny M; Pekna M
Front Immunol; 2021; 12():768198. PubMed ID: 34975856
[TBL] [Abstract][Full Text] [Related]
3. Complement: a novel factor in basal and ischemia-induced neurogenesis.
Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
[TBL] [Abstract][Full Text] [Related]
4. Intranasal C3a treatment ameliorates cognitive impairment in a mouse model of neonatal hypoxic-ischemic brain injury.
Morán J; Stokowska A; Walker FR; Mallard C; Hagberg H; Pekna M
Exp Neurol; 2017 Apr; 290():74-84. PubMed ID: 28062175
[TBL] [Abstract][Full Text] [Related]
5. Signaling through C5aR is not involved in basal neurogenesis.
Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
[TBL] [Abstract][Full Text] [Related]
7. C-C chemokine receptor type 2 (CCR2) signaling protects neonatal male mice with hypoxic-ischemic hippocampal damage from developing spatial learning deficits.
Pimentel-Coelho PM; Michaud JP; Rivest S
Behav Brain Res; 2015 Jun; 286():146-51. PubMed ID: 25746456
[TBL] [Abstract][Full Text] [Related]
8. C3a expressed in the central nervous system protects against LPS-induced shock.
Boos L; Szalai AJ; Barnum SR
Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
[TBL] [Abstract][Full Text] [Related]
9. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
[TBL] [Abstract][Full Text] [Related]
10. Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress.
Shinjyo N; de Pablo Y; Pekny M; Pekna M
Mol Neurobiol; 2016 Jul; 53(5):3076-3087. PubMed ID: 25972241
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic-ischemic brain injury stimulates inflammatory response and enzymatic activities in the hippocampus of neonatal rats.
Pimentel VC; Pinheiro FV; De Bona KS; Maldonado PA; da Silva CR; de Oliveira SM; Ferreira J; Bertoncheli CM; Schetinger MR; Da Luz SC; Moretto MB
Brain Res; 2011 May; 1388():134-40. PubMed ID: 21300037
[TBL] [Abstract][Full Text] [Related]
12. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
13. C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice.
Ten VS; Sosunov SA; Mazer SP; Stark RI; Caspersen C; Sughrue ME; Botto M; Connolly ES; Pinsky DJ
Stroke; 2005 Oct; 36(10):2244-50. PubMed ID: 16179576
[TBL] [Abstract][Full Text] [Related]
14. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury.
Graham EM; Sheldon RA; Flock DL; Ferriero DM; Martin LJ; O'Riordan DP; Northington FJ
Neurobiol Dis; 2004 Oct; 17(1):89-98. PubMed ID: 15350969
[TBL] [Abstract][Full Text] [Related]
15. G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery.
Hamel D; Sanchez M; Duhamel F; Roy O; Honoré JC; Noueihed B; Zhou T; Nadeau-Vallée M; Hou X; Lavoie JC; Mitchell G; Mamer OA; Chemtob S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):285-93. PubMed ID: 24285580
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic hypothermia modulates complement factor C3a and C5a levels in a rat model of hypoxic ischemic encephalopathy.
Shah TA; Nejad JE; Pallera HK; Lattanzio FA; Farhat R; Kumar PS; Hair PS; Bass WT; Krishna NK
Pediatr Res; 2017 Apr; 81(4):654-662. PubMed ID: 28002390
[TBL] [Abstract][Full Text] [Related]
17. Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.
Wang F; Zha WS; Zhang JX; Li SL; Wang H; Ye LP; Shen T; Wu CH; Zhu QX
Toxicol Lett; 2014 Aug; 229(1):229-39. PubMed ID: 24974766
[TBL] [Abstract][Full Text] [Related]
18. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury.
Miller JT; Bartley JH; Wimborne HJ; Walker AL; Hess DC; Hill WD; Carroll JE
BMC Neurosci; 2005 Oct; 6():63. PubMed ID: 16259636
[TBL] [Abstract][Full Text] [Related]
19. Hyperactive Behavior and Altered Brain Morphology in Adult Complement C3a Receptor Deficient Mice.
Pozo-Rodrigálvarez A; Ollaranta R; Skoog J; Pekny M; Pekna M
Front Immunol; 2021; 12():604812. PubMed ID: 33692783
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen induces endogenous neural stem cells to proliferate and differentiate in hypoxic-ischemic brain damage in neonatal rats.
Yang YJ; Wang XL; Yu XH; Wang X; Xie M; Liu CT
Undersea Hyperb Med; 2008; 35(2):113-29. PubMed ID: 18500076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
